Authors:
Mizera-Nyczak, E
Dyszkiewicz, W
Heider, KH
Zeromski, J
Citation: E. Mizera-nyczak et al., Isoform expression of CD44 adhesion molecules, Bcl-2. p53 and Ki-67 proteins in lung cancer, TUMOR BIOL, 22(1), 2001, pp. 45-53
Authors:
Stroomer, JWG
Roos, JC
Sproll, M
Quak, JJ
Heider, KH
Wilhelm, BJ
Castelijns, JA
Meyer, R
Kwakkelstein, MO
Snow, GB
Adolf, GR
van Dongen, GAMS
Citation: Jwg. Stroomer et al., Safety and biodistribution of (99m)technetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients, CLIN CANC R, 6(8), 2000, pp. 3046-3055
Authors:
Van Hal, NLW
Van Dongen, GAMS
Ten Brink, CBM
Heider, KH
Rech-Weichselbraun, I
Snow, GB
Brakenhoff, RH
Citation: Nlw. Van Hal et al., Evaluation of soluble CD44v6 as a potential serum marker for head and necksquamous cell carcinoma, CLIN CANC R, 5(11), 1999, pp. 3534-3541
Authors:
Schuster-Kolbe, J
Ludwig, H
Adolf, GR
Heider, KH
Citation: J. Schuster-kolbe et al., Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19(+) B cells of patients with multiple myeloma and healthy individuals, LEUK LYMPH, 34(1-2), 1999, pp. 95-103
Authors:
Beham-Schmid, C
Heider, KH
Hoeffler, G
Zatloukal, K
Citation: C. Beham-schmid et al., Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse, J PATHOLOGY, 186(4), 1998, pp. 383-389